Metabolic support of the critically ill: 2008 update

Minerva Anestesiologica

Volumn 74, Issue 12, 2008, Pages 709-713

  Iapichino, G ^a   Radrizzani, D ^b   Destrebecq, A ^a   Vincenzi, M ^c   Zanello, M ^c  

^a UNIVERSITY OF MILAN   (Italy)

^b Civil Hospital   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Blood glucose; Critical illness; Fatty acids, omega 3; Glutamine; Metabolism

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ARGININE; ASCORBIC ACID; BETA CAROTENE; GLUTAMINE; ICOSAPENTAENOIC ACID; INSULIN; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; SELENIUM; TRACE ELEMENT;

AMINO ACID SYNTHESIS; BURN PATIENT; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; DIET SUPPLEMENTATION; ENTERIC FEEDING; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; INFLAMMATORY DISEASE; INSULIN TREATMENT; INTENSIVE CARE; MORTALITY; NUTRITIONAL SUPPORT; OXIDATIVE STRESS; REVIEW; SEPSIS;

ANTIOXIDANTS; BLOOD GLUCOSE; CRITICAL ILLNESS; FATTY ACIDS; GLUTAMINE; HUMANS; METABOLISM; NUTRITIONAL SUPPORT;

EID: 59849114272     PISSN: 03759393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (44)

1. Weimann A, Braga M, Harsanyi L, Laviano A, Lijungqvist P, Soeters P et al. ESPEN Guidelines on enteral nutrition: surgery including organ transplantation. Clin Nutr 2006;25:224-44.
2. Radrizzani D, Bertolini G, Facchini R, Simini B, Bruzzone P, Zanforlin G et al. Early enteral immunonutrition vs parenteral nutrition in critical patients without severe sepsis: a radomized clinical trial. Intensive Care Med 2006;32:1191-8.
3. Kreymann KG, Berger MM, Deutz MEP, Hiesmayr M, Jolliet P, Kazandjiev G et al. ESPEN Guidelines on enteral nutrition: Intensive care. Clin Nutr 2006;25:210-23.
4. Bertolini G, Iapichino G, Radrizzani D, Facchini R, Simini B, Bruzzone P et al. Early enteral immunonutrition in patients with severe sepsis. Results of an interim analysis of a randomized multicentre clinical trial. Intensive Care Med 2003;29:834-40.
5. Biolo G, Zorat F, Antonione R, Ciocchi B. Muscle glutamine depletion in the intensive care unit. Int J Biochem Cell Biol 2005;37:2169-79.
6. Vermeulen MAR, van de Poll MCG, Ligthart-Melis GC, Dejong CHC, van de Toll MP, Boelens PG et al. Specific amino acids in the critically ill patient. Exogenous glutamine/arginine: a common denominator? Crit Care Med 2007;35 Suppl:568-76.
7. Flaering UB, Rooyackers OE, Wenerman J. Glutamine attenuates post-traumatic glutathione depletion in human muscle. Clin Sci 2003;104:275-82.
8. Wischmeyer PE. Glutamine: role in gut protection in critical illness. Curr Opin Clin Nutr Metab Care 2006;9:607-12.
9. Radrizzani D, Iapichino G, Cambisano M, Bonetti G, Ronzoni G, Colombo A. Peripheral, visceral and body nitrogen balance of catabolic patients, without and with parenteral nutrition. Intensive Care Med 1988;14:212-6.
10. Iapichino G, Radrizzani D, Colombo A, Bonetti G, Bordoni A, Breda G et al. Metabolismo energetico e flusso di metaboliti dal tessuto muscolare durante TPN di pazienti traumatizzati. Minerva Anestesiol 1995;61:1-7.
11. Iapichino G, Radrizzani D, Bonetti G, Colombo A, Leoni L, Ronzoni G et al. Influence of parenteral nutrition on leg nitrogen exchange in injured patients. Crit Care Med 1990;18:1367-73.
12. Wenerman J. Suggestions for present and future use of parenteral glutamine. Clin Nutr 2004;Suppl 1:37-42.
13. Bongets T, Griffit RD, McArdle A. Exogenous glutamine: the clinical evidence. Crit Care Med 2007;35 Suppl:545-52.
14. De Cicco M, Malafronte M, Fantin D, Dal Mas V, Lorenzon S, Caserta M et al. Treating hyperglycemia improves skeletal muscle protein metabolism in critically ill patients. Minerva Anestesiol 2007;73(10 Suppl 2):51-2.
15. Biolo G, De Cicco M, Lorenzon S, Dal Mas V, Fantin D, Paroni R et al. Treating hyperglycemia improves skeletal muscle protein metabolism in cancer patients after major surgery. Crit Care Med. In press 2008.
16. Vendemiale G, Grattagliano I, Altomare E. An update on the role of free radicals and antioxidant defence in human disease. Int J Clin Lab Res 1999;29:49-55.
17. Therond P, Bonnefont-Rousselot D, Davit-Spraul A, Conti M, Legrand A. Biomarkers of oxidative stress: an analytical approach. Curr Clin Nutr Metab Care 2000;3:373-84.
18. Leverve XM. Mitochondrial function and substrate availability. Crit Care Med 2007;36 Suppl:454-60.
19. Lovat R, Preiser JC. Antioxidant therapy in intensive care. Curr Opin Crit Care 2003;9:266-70.
20. Protti A, Singer M. Oxidative stress and critical illness. Minerva Anestesiol 2007;73:255-7.
21. Heyland DK, Dhaliwal R, Suchner U, Berger MM. Antioxidant nutrients: a systemic review of trace elements and vitamins in the critically ill patient. Intensive Care Med 2005;31:327-37.
22. Avenell A, Noble DW, Barr J, Engelhardt T. Selenium supplementation for critically ill adofts. The Cochrane Library, 2006, Issue 1.
23. Berger MM, Chioléro RL. Antioxidant supplementation in septic and systemic inflammatory response syndrome. Crit Care Med 2007;35 Suppl:584-90.
24. Grimm H, Mayer K, Mayser P, Eigenbro E. Regulatory potential of n-3 fatty acids in immunological and inflammatory processes. Br J Nutr 2002;87 Suppl 1:S59-67.
25. Calder PC. N-3 polyunsaturated fatty acids and inflammation: from molecular biology to the clinic. Lipids 2003;38:343-52.
26. Singer P, Zolotarski V, Yussim A, Lustig S, Attal-Singer J, Cohen J. Renal effects of parenteral fish oil administered to heart-beating organ donors and renal-transplant recipients: a tolerance study. Clin Nutr 2004;23:597-60.
27. Schauder P, Röhm U, Schäfer G, Korff G, Schenk HD. Impact of fish oil enriched total parenteral nutrition on DNA synthesis, cytokine release and receptor expression by lymphocytes in the postoperative period. Br J Nutr 2002;87 Suppl 1:103-10.
28. Singer P, Theilla M, Fisher H, Gibstein L, Grozovski E, Cohen J. Benefit of an enteral diet enriched with eicosapentaenoic acid and gamma-linolenic acid in ventilated patients with acute lung injury. Crit Care Med 2006;34:1033-8.
29. Pontes-Arruda A, Aragão AM, Albuquerque JD. Effects of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock. Crit Care Med 2006;34:2325-33.
30. Heller AR, Rössler S, Rainer L, Stehr S, Heller S, Koch R et al. Omega-3 fatty acids improve the diagnosis-related clinical outcome. Crit Care Med 2006;34:972-9.
31. Al Saady NM, Blackmore CM, Bennett ED. High fat, low carbohydrate, enteral feeding lowers PaCO2 and reduces the period of ventilation in artificially ventilated patients. Intensive Care Med 1989;15:290-5.
32. Van den Berg B, Bogaard JM, Hop WC. High fat, low carbohydrate, enteral feeding in patients weaning from the ventilator. Intensive Care Med 1994;20:470-5.
33. Mesejo A, Acosta JA, Ortega C, Vila J, Fernandez M, Ferreres J et al. Comparison of a high-protein disease-specific enteral formula with a high-protein enteral formula in hyperglycemic critically ill patients. Clin Nutr 2003;22:295-305.
34. Minneci PC, Eichacker PQ, Dammer RL, Banks SM, Natanson C, Deans KJ. The importance of usual care control groups for safety monitoring and validity during critical care research. Intensive Care Med 2008;34:942-7.
35. The Acute Respirator Distress Syndrome Network. Ventilation with lower tidal volumes as comparated with traditional tidal volumes for acute long injury the acute respiratory distress syndrome. N Engl J Med 2000;342:1301-8.
36. Cerra FB, Benitez MR, Blackburn GL, Irwin RS, Jeejeebhoy K, Katz DP et al. A Consensus Statement of the American College of Chest Physicians. Chest 1997;111:769-78.
37. Van den Betghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx P, Schetz M et al. Intensive insulin therapy in critcally ill patients. N Engl J Med 2001;345:1359-67.
38. Van den Berghe G, Wilmer A, Hermans G, Meeserman W, Wouters P, Milants I et al. Intensive insulin therapy in the medical ICU. N Engl J Med 2006;354:449-61.
39. Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N et al. for the German Competence Network Sepsis (SepNet). Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008;358:125-39.
40. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med 2000;34:17-60.
41. Marik PE, Varonb J. Intensive insulin therapy in the ICU: is it now time to jump off the bandwagon? Resuscitation 2007;74:191-3.
42. Ellger B, Debaveye Y, Vanhorebeek I, Giulietti A, Van Etten E, Herijgers P et al. Survival benefits of intensive insulin therapy in critical illness. Impact of maintaining normoglycaemia versus glycaemia independent action of insulin. Diabetes 2006;55:1096-104.
43. Iapichino G, Radrizzani D, Giacomini M, Pezzi A, Zaniboni M, Mistraletti G. Metabolic treatment of critically ill patients: energy expenditure and energy supply. Minerva Anestesiol 2006;72:559-65.
44. Iapichino G, Radrizzani D, Armani S, Noto A, Spanu P, Mistraletti G. Metabolic treatment of critically ill patients: energy balance and substrate disposal. Minerva Anestesiol 2006;72:533-42.